Rate of incident pneumonia increased in second year after initiating treatment with proton pump inhibitors
THURSDAY, Aug. 23, 2018 (HealthDay News) — Among older adults in primary care, use of proton pump inhibitors (PPIs) is associated with greater risk of pneumonia in the second year of treatment, according to a study published in the July issue of the Journal of the American Geriatrics Society.
Jan Zirk-Sadowski, Ph.D., from the University of Exeter in the United Kingdom, and colleagues assessed associations between long-term use of PPIs and pneumonia incidence. The analysis included 75,050 older adults (≥60 years) who were in primary care and had been receiving PPIs for at least one year and 75,050 age- and sex-matched controls.
The researchers found that during the second year after initiating treatment, PPIs were associated with greater hazard of incident pneumonia (prior event rate ratio-adjusted hazard ratio, 1.82), accounting for pretreatment pneumonia rates. Across age and comorbidity subgroups, estimates were similar.
“Controversies about the validity of reported short-term harms of PPIs should not divert attention from potential long-term effects of PPI prescriptions on older adults,” the authors write.
One author disclosed financial ties to the pharmaceutical industry.
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia 
Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood 
Long-Term Proton Pump Inhibitor Use Not Linked to Gastric Adenocarcinoma 
Sugar-Sweetened Beverages May Increase Risk for Gastric Cancer 
Couples" Coping Skills Help Reduce Depression in GI Cancer Survivors 
Physical Activity Levels Linked to Risk for Digestive System Cancers 
Autoimmune Diseases Linked to Digestive System Cancers 
.jpg)
